Vijay Kumar
Stock Analyst at Evercore ISI Group
(2.25)
# 2,525
Out of 4,829 analysts
203
Total ratings
40.68%
Success rate
-4.46%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Outperform | $400 → $390 | $380.92 | +2.38% | 10 | May 2, 2025 | |
| HOLX Hologic | Maintains: In-Line | $65 → $62 | $56.75 | +9.25% | 14 | May 2, 2025 | |
| EXAS Exact Sciences | Maintains: Outperform | $60 → $66 | $51.63 | +27.83% | 4 | May 2, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Outperform | $96 → $85 | $69.87 | +21.65% | 4 | May 1, 2025 | |
| BLCO Bausch + Lomb | Maintains: Outperform | $19 → $16 | $11.27 | +37.53% | 8 | May 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $585 → $500 | $403.13 | +24.03% | 11 | Apr 24, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $110 → $112 | $102.86 | +8.89% | 6 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: In-Line | $510 → $470 | $536.51 | -12.40% | 12 | Apr 23, 2025 | |
| EW Edwards Lifesciences | Maintains: In-Line | $75 → $73 | $73.68 | -0.92% | 11 | Feb 12, 2025 | |
| MTD Mettler-Toledo International | Maintains: Outperform | $1,450 → $1,475 | $1,080.98 | +36.45% | 9 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $50 → $52 | $26.79 | +94.10% | 6 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $207 → $202 | $135.53 | +49.04% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $18 → $30 | $17.38 | +72.61% | 11 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $145 → $142 | $106.93 | +32.80% | 3 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $51 → $54 | $42.02 | +28.51% | 4 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $113 → $110 | $95.21 | +15.53% | 12 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $335 → $355 | $344.06 | +3.18% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $56 | $30.82 | +81.70% | 5 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $160 | $123.84 | +29.20% | 7 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $104 | $83.48 | +24.58% | 4 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $62 → $58 | $33.05 | +75.49% | 3 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $275 → $278 | $189.73 | +46.52% | 2 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $286 → $290 | $167.22 | +73.42% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $124 | $133.24 | -6.93% | 10 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $4.5 → $5 | $2.51 | +99.20% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $45 | $30.90 | +45.63% | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $27 | $12.02 | +124.63% | 10 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $195 → $175 | $75.76 | +130.99% | 6 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $88 → $125 | $91.25 | +36.99% | 1 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $0.74 | +840.86% | 1 | May 31, 2022 |
Stryker
May 2, 2025
Maintains: Outperform
Price Target: $400 → $390
Current: $380.92
Upside: +2.38%
Hologic
May 2, 2025
Maintains: In-Line
Price Target: $65 → $62
Current: $56.75
Upside: +9.25%
Exact Sciences
May 2, 2025
Maintains: Outperform
Price Target: $60 → $66
Current: $51.63
Upside: +27.83%
GE HealthCare Technologies
May 1, 2025
Maintains: Outperform
Price Target: $96 → $85
Current: $69.87
Upside: +21.65%
Bausch + Lomb
May 1, 2025
Maintains: Outperform
Price Target: $19 → $16
Current: $11.27
Upside: +37.53%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $585 → $500
Current: $403.13
Upside: +24.03%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $110 → $112
Current: $102.86
Upside: +8.89%
Intuitive Surgical
Apr 23, 2025
Maintains: In-Line
Price Target: $510 → $470
Current: $536.51
Upside: -12.40%
Edwards Lifesciences
Feb 12, 2025
Maintains: In-Line
Price Target: $75 → $73
Current: $73.68
Upside: -0.92%
Mettler-Toledo International
Feb 10, 2025
Maintains: Outperform
Price Target: $1,450 → $1,475
Current: $1,080.98
Upside: +36.45%
Feb 6, 2025
Maintains: In-Line
Price Target: $50 → $52
Current: $26.79
Upside: +94.10%
Jan 17, 2025
Maintains: Outperform
Price Target: $207 → $202
Current: $135.53
Upside: +49.04%
Dec 2, 2024
Upgrades: Outperform
Price Target: $18 → $30
Current: $17.38
Upside: +72.61%
Nov 26, 2024
Maintains: In-Line
Price Target: $145 → $142
Current: $106.93
Upside: +32.80%
Oct 30, 2024
Maintains: In-Line
Price Target: $51 → $54
Current: $42.02
Upside: +28.51%
Oct 1, 2024
Maintains: In-Line
Price Target: $113 → $110
Current: $95.21
Upside: +15.53%
Oct 1, 2024
Maintains: In-Line
Price Target: $335 → $355
Current: $344.06
Upside: +3.18%
Oct 1, 2024
Maintains: Outperform
Price Target: $52 → $56
Current: $30.82
Upside: +81.70%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $123.84
Upside: +29.20%
Oct 1, 2024
Maintains: Outperform
Price Target: $100 → $104
Current: $83.48
Upside: +24.58%
Oct 1, 2024
Maintains: Outperform
Price Target: $62 → $58
Current: $33.05
Upside: +75.49%
Oct 1, 2024
Maintains: Outperform
Price Target: $275 → $278
Current: $189.73
Upside: +46.52%
Oct 1, 2024
Maintains: Outperform
Price Target: $286 → $290
Current: $167.22
Upside: +73.42%
Oct 1, 2024
Maintains: Outperform
Price Target: $120 → $124
Current: $133.24
Upside: -6.93%
Aug 7, 2024
Maintains: In-Line
Price Target: $4.5 → $5
Current: $2.51
Upside: +99.20%
Jul 2, 2024
Maintains: Outperform
Price Target: $46 → $45
Current: $30.90
Upside: +45.63%
Jul 2, 2024
Maintains: Outperform
Price Target: $28 → $27
Current: $12.02
Upside: +124.63%
Jun 11, 2024
Maintains: Outperform
Price Target: $195 → $175
Current: $75.76
Upside: +130.99%
Jan 4, 2024
Upgrades: Outperform
Price Target: $88 → $125
Current: $91.25
Upside: +36.99%
May 31, 2022
Initiates: Outperform
Price Target: $7
Current: $0.74
Upside: +840.86%